Market Overview

Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson

Related VRX
Early Global News: Russia Denis Airspace Violation, Ackman Boosts Stake In Valeant, And German Company That's A Huge Threat To Tesla
The Valeant News No One Is Talking About
Mallinckodt: Will 2,000% Price Hike Of Infant Drug Draw Lawmakers' Attention? (Seeking Alpha)
Related AGN
Will The New Pfizer Be A Winner? SunTrust Analyst Thinks So, Upgrades Stock
EXCLUSIVE: FBB's Mike Bailey On Pfizer-Allergan Deal, Taxes, Rate Hike And Biotech Picks
Stocks Edge Higher In Pre-Thanksgiving Trade; Pfizer Leads Dow (Investor's Business Daily)

Allergan Inc. (NYSE: AGN) shares bumped up more than 2 percent on a rumor that Hedge fund Paulson & Co. acquiredsix6 million shares.

The report by Reuters said Paulson backs Valeant Pharmaceuticals (NYSE: VRX) in its proxy battle to acquire Allergan and the new stake puts Paulson among Allergan's top holders.

Valeant needs support from 25 percent of Allergan's holders in order to call a special shareholder meeting to vote on its $53 billion bid.

Allergan has called the offer "grossly inadequate."

With a current market capitalization of about $50.3 billion, Allergan traded recently at $69.02, up 2.2 percent.

Posted-In: News Rumors


Related Articles (AGN + VRX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters